Pilot Projects

Approved Projects

Non-lamellar liquid crystals as potential matrices for non-invasive sampling of endogenous biomarkers targeting inflammatory skin disorders

This project aims to develop non-invasive or minimally invasive monitoring of endogeneous biomarkers targeting inflammatory skin disorders like contact allergy and cancer.

The main goal for this specific project is to further explore and develop the potential of using semisolid to ‘solid’ bicontinuous cubic liquid crystals as matrices for topical sampling of low molecular weight biomarkers (< 500 Da) that can diffuse through skin. The large interfacial area, comprised by these specific liquid crystals, separating their interconnected polar and apolar domains allow them to accommodate various types of solutes of hydrophilic, amphiphilic, or lipophilic nature.

Starting date:
01 Nov, 2024

Research infrastructures:

  • Biofilms Research Center for Biointerfaces and Open Lab at Malmö University
  • CoSAXS beamline at MAX IV
  • Skåne University Hospital Patient study

HALRIC partners:

  • Malmö University (MaU)
  • University of Copenhagen (UCPH)
  • Skåne University Hospital (SUS)
  • MAX IV
  • Sensach AB (industry partner)

Project participants:

  • Stella Prastitou (MaU)
  • Johan Engblom (MaU)
  • Emelie Nilsson (MaU)
  • Ben Boyd (UCPH)
  • Jacob Kirkengsaard (UCPH)
  • Cecilia Svedman (SUS)
  • Henrik Luu (SUS)
  • Lena Holmström (SUS)
  • Ann Terry (MAXIV)
  • Sebastian Björklund (Sensach AB)